Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-061600

Director sold 1,184 shares at $14.20 ($16,813)

  • Director acquired 2,366 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gallagher Carol Giltner · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Exercise or conversion : show line 1 in the form +1,549 110,105 D
2017-11-15 Exercise or conversion : show line 2 in the form +817 110,922 D
2017-11-16 Sale : show line 3 in the form −1,184 $14.20 $16,813 109,738 D
Open-market sales · 1,184 sh · avg $14.20 · $16,813

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-15 Exercise or conversion : show line 4 in the form Restricted Stock Units −1,549 1,548 D
2017-11-15 Exercise or conversion : show line 5 in the form Restricted Stock Units −817 1,362 D
Loading xslF345X03/doc4.xml…